An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

The Food and Drug Administration approved the pill from Vertex Pharmaceuticals for acute pain that often occurs after surgery ...

You enjoy reading prose laden with immersive descriptionsStarward Vector has plenty of words and minutiae, accompanied by some portraits and an astounding map design. The bulk of the action is ...

VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy, UC101, received Investigational New Drug (IND) approval from the U.S.

Last northern autumn, Nvidia open sourced its BioNeMo family of GPU-accelerated machine learning frameworks for drug development and molecular design. The company has also taken steps to repackage ...

It’s true to say that drug usage has a variety of negative consequences for its users and, on the whole, governments are right to advise against it. People in New York who smoke cannabis should ...

Some species of caterpillar come armed with powerful venoms. Harnessing them could help us design new drugs. When you think of venomous animals, caterpillars probably aren't the first thing that ...

Blockbuster obesity drugs such as Ozempic have been celebrated for their ability to promote weight loss and treat a surprising range of other conditions, from heart problems to Parkinson’s disease.

Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash ...